Lifting full-year organic revenue growth guidance to 9% to 10%, from 8% to 10%
Raising full-year adjusted EPS guidance to $2.65 to $2.75, from $2.50 to $2.70
Third quarter revenue growth of 9% on a reported basis, 16% organically
Reported earnings per share of $0.07, adjusted earnings per share of $0.79

Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world's most challenging water issues, today reported third quarter revenue of $1.4 billion, surpassing previous guidance, with strong commercial and operational execution. While orders were down 7 percent on a reported basis, they were down 1 percent organically, with the difference due to currency. The Company reported resilient underlying global demand with strong backlog growth.

Earnings also exceeded Xylem's previous guidance, with strong margin performance. Net income was $12 million, or $0.07 per share. Net income margin decreased 810 basis points to 0.9 percent. These results were mainly driven by a previously announced, one-time non-cash pension plan settlement. Adjusted net income was $144 million, or $0.79 per share, which excludes the impacts of restructuring, realignment and special charges. Third quarter adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin was 18.3 percent, reflecting a year-over-year increase of 40 basis points. Strong price realization offset inflation and, coupled with productivity savings, drove the margin expansion, exceeding the impact of strategic investments.

"The team delivered very strong performance across all our regions, driving third quarter results well above expectations on all key metrics," said Patrick Decker, Xylem president and CEO. "Demand remains resilient across our largest end-markets, and disciplined operational execution delivered double-digit revenue growth with strong margin expansion."

"We anticipate our momentum will continue driven by the essential nature of the services we provide. Our strong backlog and bidding pipelines support that outlook. The team, from our factories to our channel partners, continues to demonstrate resilience in managing through a dynamic environment, as our customers and communities invest in essential water infrastructure. Based on this strength, we are further raising our full-year guidance for both revenue and earnings per share, with continued confidence in Xylem's longer-term growth outlook."

Outlook

Xylem now expects full-year 2022 organic revenue growth to be in the range of 9 to 10 percent, and approximately 4 percent on a reported basis. This represents a raise of the low end of the Company's previous full-year organic revenue guidance of 8 to 10 percent, and 3 to 5 percent on a reported basis. Full-year 2022 adjusted EBITDA margin is now expected to be approximately 17.0 percent, raising the low end of the previous range of 16.5 to 17.0 percent. This results in adjusted earnings per share of $2.65 to $2.75, an increase from the previous range of $2.50 to $2.70. The increased guidance reflects strong demand, gradual easing of supply chain constraints, and price realization, partially offset by inflation and foreign exchange headwinds.

Further 2022 planning assumptions are included in Xylem's third quarter 2022 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Third Quarter Segment Results

Water Infrastructure

Xylem's Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

Third quarter 2022 revenue was $574 million, a 5 percent increase, 13 percent organically, compared with third quarter 2021. This strong growth was driven by price realization, robust utilities demand in the US and Western Europe, and dewatering demand in the US and Emerging Markets.

Third quarter reported operating income for the segment was $104 million, a 3.0 percent increase versus the comparable period last year. Adjusted operating income for the segment, which excludes $3 million of restructuring and realignment costs, was $107 million, a 4.9 percent increase versus the comparable period last year. Reported operating margin for the segment was 18.1 percent, down 40 basis points versus the prior year, and adjusted operating margin was 18.6 percent, flat versus the prior year. Adjusted EBITDA margin was 20.7 percent, down 50 basis points from the prior year. Favorable price realization net of inflation was offset by strategic investments and unfavorable mix.

Applied Water

Xylem's Applied Water segment consists of its portfolio of businesses in industrial, commercial building, and residential applications.

Third quarter 2022 Applied Water revenue was $458 million, a 15 percent increase, 20 percent organically, year-over-year. The robust growth was driven by strong price realization and backlog execution across all end markets.

Third quarter reported operating income for the segment was $77 million, a 28.3 percent increase versus comparable period last year, and adjusted operating income, which excludes $1 million of restructuring and realignment costs, was $78 million, a 25.8 percent increase versus the comparable period last year. The segment reported operating margin was 16.8 percent, up 180 basis points versus the prior year period. Adjusted operating margin increased 150 basis points over the prior year period to 17.0 percent. Adjusted EBITDA margin was 18.1 percent, up 110 basis points from the prior year. Margin expansion was driven by strong price realization more than offsetting inflation coupled with productivity savings.

Measurement & Control Solutions

Xylem's Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics, and analytic instrumentation.

Third quarter 2022 Measurement & Control Solutions revenue was $348 million, up 9 percent, 15 percent organically, versus the prior year. While chip supply remains constrained, we continue to see modest sequential improvement, and strength in our water quality test applications.

Third quarter reported operating income for the segment was $(2) million, a 128.6 percent decrease versus the comparable period last year, and adjusted operating income, which excludes $2 million of restructuring and realignment costs and $12 million of special charges, was $12 million, a 100 percent increase versus the comparable period last year. The segment reported operating margin was (0.6) percent, down 280 basis points versus the prior year period. Adjusted operating margin of 3.4 percent increased 150 basis points over the prior year period. Adjusted EBITDA margin was 13.8 percent, down 40 basis points from the prior year. Strong price realization, volume growth and productivity savings were more than offset by higher inflation.

Supplemental information on Xylem's third quarter 2022 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our 17,000 diverse employees delivered revenue of $5.2 billion in 2021. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words "anticipate," "estimate," "expect," "project," "intend," "plan," "contemplate," "predict," "forecast," "likely," "believe," "target," "will," "could," "would," "should," "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, and may continue to be, amplified by impacts from changes in international conditions, including as a result of the war between Russia and Ukraine, the coronavirus ("COVID-19") pandemic and macroeconomic conditions, including inflation. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, inflation, interest rates and related monetary policy by governments in response to inflation, and the strength of the residential and commercial real estate markets, on economic activity and our operations; geopolitical events, including the war between Russia and Ukraine, and regulatory, economic and other risks associated with our global sales and operations, including with respect to domestic content requirements applicable to projects with governmental funding; continued uncertainty around the ongoing impacts of the COVID-19 pandemic on the macroeconomy and our business, operations, growth, and financial condition; actual or potential other epidemics, pandemics or global health crises; availability, shortage or delays in receiving electronic components (in particular, semiconductors), parts, and raw materials from our supply chain; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, tight labor markets, prevailing price changes, tariffs and other factors; demand for our products; disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our products; disruptions in operations at our facilities or that of third parties upon which we rely; ability to retain and attract senior management and other diverse and key talent, as well as competition for overall talent and labor; difficulty predicting our financial results; defects, security, warranty and liability claims, and recalls with respect to products; availability, regulation or interference with radio spectrum used by certain of our products; uncertainty related to restructuring and realignment actions and related costs and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute and integrate acquisitions; volatility in served markets or impacts on business and operations due to weather conditions, including the effects of climate change; fluctuations in foreign currency exchange rates; our ability to borrow or refinance our existing indebtedness and uncertainty around the availability of liquidity sufficient to meet our needs; risk of future impairments to goodwill and other intangible assets; failure to comply with, or changes in, laws or regulations, including those pertaining to anti-corruption, data privacy and security, export and import, our products, competition, and the environment and climate change; changes in our effective tax rates or tax expenses; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; and other factors set forth under "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2021 ("2021 Annual Report") and in subsequent filings we make with the Securities and Exchange Commission ("SEC").

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors or are required to be disclosed in our filings with the SEC. In addition, historical, current, and forward-looking social, environmental and sustainability related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this Report. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)

	Three Months					Nine Months
For the periods ended September 30,	2022		2021			2022		2021
Revenue	$	1,380	$	1,265		$	4,016	$	3,872
Cost of revenue		856		793			2,505		2,390
Gross profit		524		472			1,511		1,482
Selling, general and administrative expenses		294		273			912		878
Research and development expenses		47		49			152		152
Restructuring and asset impairment charges (recoveries)		15		(2	)		22		7
Operating income		168		152			425		445
Interest expense		12		21			37		63
U.K. pension settlement expense		140		—			140		—
Other non-operating income, net		1		2			2		1
Gain from sale of business		—		—			1		2
Income before taxes		17		133			251		385
Income tax expense		5		19			45		71
Net income	$	12	$	114		$	206	$	314
Earnings per share:
Basic	$	0.07	$	0.63		$	1.14	$	1.74
Diluted	$	0.07	$	0.63		$	1.14	$	1.73
Weighted average number of shares:
Basic		180.2		180.2			180.2		180.2
Diluted		180.9		181.6			180.9		181.5


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except per share amounts)

	September 30, 2022			December 31, 2021

ASSETS
Current assets:
Cash and cash equivalents	$	1,186		$	1,349
Receivables, less allowances for discounts, returns and credit losses of $46 and $44 in 2022 and 2021, respectively		1,018			953
Inventories		837			700
Prepaid and other current assets		150			158
Total current assets		3,191			3,160
Property, plant and equipment, net		585			644
Goodwill		2,637			2,792
Other intangible assets, net		933			1,016
Other non-current assets		760			664
Total assets	$	8,106		$	8,276
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	618		$	639
Accrued and other current liabilities		828			752
Short-term borrowings and current maturities of long-term debt		483			—
Total current liabilities		1,929			1,391
Long-term debt		1,880			2,440
Accrued post-retirement benefits		361			438
Deferred income tax liabilities		260			287
Other non-current accrued liabilities		454			494
Total liabilities		4,884			5,050

Stockholders' equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 196.0 shares and 195.6 shares in 2022 and 2021, respectively		2			2
Capital in excess of par value		2,123			2,089
Retained earnings		2,197			2,154
Treasury stock – at cost 15.8 shares and 15.2 shares in 2022 and 2021, respectively		(708	)		(656	)
Accumulated other comprehensive loss		(399	)		(371	)
Total stockholders' equity		3,215			3,218
Non-controlling interests		7			8
Total equity		3,222			3,226
Total liabilities and stockholders' equity	$	8,106		$	8,276


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)

For the nine months ended September 30,	2022			2021
Operating Activities
Net income	$	206		$	314
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		83			90
Amortization		93			96
Share-based compensation		28			25
Restructuring and asset impairment charges		22			7
U.K. pension settlement		140			—
Gain from sale of business		(1	)		(2	)
Other, net		(9	)		3
Payments for restructuring		(7	)		(21	)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables		(145	)		(78	)
Changes in inventories		(214	)		(135	)
Changes in accounts payable		47			19
Changes in accrued taxes		(12	)		—
Other, net		3			—
Net Cash – Operating activities		234			318
Investing Activities
Capital expenditures		(148	)		(127	)
Proceeds from sale of business		1			2
Proceeds from the sale of property, plant and equipment		3			1
Cash received from investments		5			—
Cash paid for investments		(9	)		—
Cash received from cross currency swaps		24			11
Other, net		1			—
Net Cash – Investing activities		(123	)		(113	)
Financing Activities
Long-term debt repaid		—			(600	)
Repurchase of common stock		(52	)		(68	)
Proceeds from exercise of employee stock options		6			15
Dividends paid		(163	)		(152	)
Other, net		(1	)		(1	)
Net Cash – Financing activities		(210	)		(806	)
Effect of exchange rate changes on cash		(64	)		(19	)
Net change in cash and cash equivalents		(163	)		(620	)
Cash and cash equivalents at beginning of year		1,349			1,875
Cash and cash equivalents at end of period	$	1,186		$	1,255
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	67		$	83
Income taxes (net of refunds received)	$	57		$	71

Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.

"Organic revenue" and "Organic orders" defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

"Constant currency" defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the US dollar.

"EBITDA" defined as earnings before interest, taxes, depreciation and amortization expense. "Adjusted EBITDA" and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.

"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and "Adjusted EPS" defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.

"Free Cash Flow" defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and "Free Cash Flow Conversion" defined as Free Cash Flows divided by net income, excluding the gain on sale of businesses, non-cash impairment charges and significant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" do not consider certain non-discretionary cash payments, such as debt.

"Realignment costs" defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

"Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for costs related to the UK pension plan buyout.

"Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.


Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders ($ Millions)

	(As Reported - GAAP)						(As Adjusted - Organic)						Constant Currency
		(A)	(B)				(C)	(D)	(E) = B+C+D		(F) = E/A		(G) = (E - C) / A
			Change		% Change		Acquisitions / Divestitures		Change		% Change
	Orders	Orders	2022 v. 2021		2022 v. 2021		Acquisitions / Divestitures	FX Impact	Adj. 2022 v. 2021		Adj. 2022 v. 2021
	2022	2021
Nine Months Ended September 30
Xylem Inc.	4,818	4,716	102		2	%	18	189	309		7	%	6	%
Water Infrastructure	1,985	1,873	112		6	%	0	113	225		12	%	12	%
Applied Water	1,394	1,409	(15	)	-1	%	0	45	30		2	%	2	%
Measurement & Control Solutions	1,439	1,434	5		0	%	18	31	54		4	%	3	%

Quarter Ended September 30
Xylem Inc.	1,419	1,518	(99	)	-7	%	7	82	(10	)	-1	%	-1	%
Water Infrastructure	594	623	(29	)	-5	%	0	47	18		3	%	3	%
Applied Water	409	446	(37	)	-8	%	0	20	(17	)	-4	%	-4	%
Measurement & Control Solutions	416	449	(33	)	-7	%	7	15	(11	)	-2	%	-4	%

Quarter Ended June 30
Xylem Inc.	1,684	1,660	24		1	%	5	67	96		6	%	5	%
Water Infrastructure	731	639	92		14	%	0	42	134		21	%	21	%
Applied Water	480	486	(6	)	-1	%	0	15	9		2	%	2	%
Measurement & Control Solutions	473	535	(62	)	-12	%	5	10	(47	)	-9	%	-10	%

Quarter Ended March 31
Xylem Inc.	1,715	1,538	177		12	%	6	40	223		14	%	14	%
Water Infrastructure	660	611	49		8	%	0	24	73		12	%	12	%
Applied Water	505	477	28		6	%	0	10	38		8	%	8	%
Measurement & Control Solutions	550	450	100		22	%	6	6	112		25	%	24	%


Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue ($ Millions)

	(As Reported - GAAP)						(As Adjusted - Organic)						Constant Currency
		(A)	(B)				(C)	(D)	(E) = B+C+D		(F) = E/A		(G) = (E - C) / A
			Change		% Change		Acquisitions / Divestitures		Change		% Change
	Revenue	Revenue	2022 v. 2021		2022 v. 2021		Acquisitions / Divestitures	FX Impact	Adj. 2022 v. 2021		Adj. 2022 v. 2021
	2022	2021
Nine Months Ended September 30
Xylem Inc.	4,016	3,872	144		4	%	9	173	326		8	%	8	%
Water Infrastructure	1,696	1,625	71		4	%	0	99	170		10	%	10	%
Applied Water	1,312	1,207	105		9	%	0	44	149		12	%	12	%
Measurement & Control Solutions	1,008	1,040	(32	)	-3	%	9	30	7		1	%	0	%

Quarter Ended September 30
Xylem Inc.	1,380	1,265	115		9	%	4	80	199		16	%	15	%
Water Infrastructure	574	547	27		5	%	0	46	73		13	%	13	%
Applied Water	458	400	58		15	%	0	21	79		20	%	20	%
Measurement & Control Solutions	348	318	30		9	%	4	13	47		15	%	14	%

Quarter Ended June 30
Xylem Inc.	1,364	1,351	13		1	%	3	60	76		6	%	5	%
Water Infrastructure	589	569	20		4	%	0	34	54		9	%	9	%
Applied Water	429	414	15		4	%	0	15	30		7	%	7	%
Measurement & Control Solutions	346	368	(22	)	-6	%	3	11	(8	)	-2	%	-3	%

Quarter Ended March 31
Xylem Inc.	1,272	1,256	16		1	%	2	33	51		4	%	4	%
Water Infrastructure	533	509	24		5	%	0	19	43		8	%	8	%
Applied Water	425	393	32		8	%	0	8	40		10	%	10	%
Measurement & Control Solutions	314	354	(40	)	-11	%	2	6	(32	)	-9	%	-10	%


Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income ($ Millions)


	Q1				Q2				Q3				YTD
	2022		2021		2022		2021		2022		2021		2022		2021
Total Revenue
• Total Xylem	1,272		1,256		1,364		1,351		1,380		1,265		4,016		3,872
• Water Infrastructure	533		509		589		569		574		547		1,696		1,625
• Applied Water	425		393		429		414		458		400		1,312		1,207
• Measurement & Control Solutions	314		354		346		368		348		318		1,008		1,040

Operating Income (Loss)
• Total Xylem	111		133		146		160		168		152		425		445
• Water Infrastructure	74		71		108		93		104		101		286		265
• Applied Water	59		66		61		64		77		60		197		190
• Measurement & Control Solutions	(10	)	9		(5	)	13		(2	)	7		(17	)	29
• Total Segments	123		146		164		170		179		168		466		484

Operating Margin
• Total Xylem	8.7	%	10.6	%	10.7	%	11.8	%	12.2	%	12.0	%	10.6	%	11.5	%
• Water Infrastructure	13.9	%	13.9	%	18.3	%	16.3	%	18.1	%	18.5	%	16.9	%	16.3	%
• Applied Water	13.9	%	16.8	%	14.2	%	15.5	%	16.8	%	15.0	%	15.0	%	15.7	%
• Measurement & Control Solutions	-3.2	%	2.5	%	-1.4	%	3.5	%	-0.6	%	2.2	%	-1.7	%	2.8	%
• Total Segments	9.7	%	11.6	%	12.0	%	12.6	%	13.0	%	13.3	%	11.6	%	12.5	%

Special Charges
• Total Xylem	1		2		1		0		13		1		15		3
• Water Infrastructure	0		0		0		0		0		0		0		0
• Applied Water	0		1		0		0		0						1
• Measurement & Control Solutions	0		0		1		0		12		0		13		0
• Total Segments	0		1		1		0		12		0		13		1

Restructuring & Realignment Costs
• Total Xylem	4		8		8		6		6		2		18		16
• Water Infrastructure	1		5		3		4		3		1		7		10
• Applied Water	1		1		2		2		1		2		4		5
• Measurement & Control Solutions	2		2		3		0		2		(1	)	7		1
• Total Segments	4		8		8		6		6		2		18		16

Adjusted Operating Income (Loss)
• Total Xylem	116		143		155		166		187		155		458		464
• Water Infrastructure	75		76		111		97		107		102		293		275
• Applied Water	60		68		63		66		78		62		201		196
• Measurement & Control Solutions	(8	)	11		(1	)	13		12		6		3		30
• Total Segments	127		155		173		176		197		170		497		501

Adjusted Operating Margin
• Total Xylem	9.1	%	11.4	%	11.4	%	12.3	%	13.6	%	12.3	%	11.4	%	12.0	%
• Water Infrastructure	14.1	%	14.9	%	18.8	%	17.0	%	18.6	%	18.6	%	17.3	%	16.9	%
• Applied Water	14.1	%	17.3	%	14.7	%	15.9	%	17.0	%	15.5	%	15.3	%	16.2	%
• Measurement & Control Solutions	-2.5	%	3.1	%	-0.3	%	3.5	%	3.4	%	1.9	%	0.3	%	2.9	%
• Total Segments	10.0	%	12.3	%	12.7	%	13.0	%	14.3	%	13.4	%	12.4	%	12.9	%


Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)

		Q3 2022										Q3 2021
		As Reported			Adjustments				Adjusted			As Reported			Adjustments				Adjusted
	Total Revenue		1,380							1,380			1,265							1,265
	Operating Income		168			19		a		187			152			3		a		155
	Operating Margin		12.2	%						13.6	%		12.0	%						12.3	%
	Interest Expense		(12	)		0				(12	)		(21	)		0				(21	)
	Other Non-Operating Income (Expense)		1			1		b		2			2			1		b		3
	UK Pension Buyout Settlement		(140	)		140		b		0										0
	Gain/(Loss) From Sale of Business									0										0
	Income before Taxes		17			160				177			133			4				137
	Provision for Income Taxes		(5	)		(28	)	c		(33	)		(19	)		(2	)	c		(21	)
	Net Income Attributable to Xylem		12			132				144			114			2				116
	Diluted Shares		181							181			182							182
	Diluted EPS	$	0.07		$	0.72			$	0.79		$	0.63		$	0.00			$	0.63

	Year-over-year currency translation impact on current year diluted EPS	$	0.03		($	0.17	)		($	0.14	)
	Diluted EPS at Constant Currency	$	0.04		$	0.89			$	0.93

a	Quarter-to-date: Restructuring & realignment costs of $6 million in 2022 and $2 million in 2021, as well as special charges of $13 million in 2022 ($1 million UK pension plan charges and $12 million asset impairment charges) and $1 million in 2021 for UK pension plan charges.
b	Quarter-to-date: Special non-operating charges consist of $141 million in 2022 related to UK pension plan charges and buyout settlement and $1 million in 2021 for costs related to the UK pension plan.
c	Quarter-to-date: Net tax impact on restructuring & realignment costs of $1 million in 2022 and $1 million in 2021; net tax impact on special charges of $25 million in 2022; and $2 million in 2022 and $1 million in 2021 of negative impact from tax related special benefits to GAAP tax, respectively.


Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow ($ Millions)

	Q1				Q2				Q3				Year-to-Date

	2022		2021		2022		2021		2022		2021		2022		2021

Net Cash - Operating Activities	($81	)	($26	)	$113		$232		$202		$112		$234		$318

Capital Expenditures - PP&E	(31	)	(22	)	(30	)	(25	)	(37	)	(33	)	(98	)	(80	)
Capital Expenditures - Software	(18	)	(17	)	(16	)	(16	)	(16	)	(14	)	(50	)	(47	)
Capital Expenditures	(49	)	(39	)	(46	)	(41	)	(53	)	(47	)	(148	)	(127	)
Free Cash Flow	($130	)	($65	)	$67		$191		$149		$65		$86		$191
Net Income	82		87		112		113		12		114		206		314
Gain/(Loss) from sale of business	1		0		0		2		0		0		1		2
Restructuring & Realignment Charges - non-cash impairment	0		(1	)	0		0		0		0		0		(1	)
UK pension buyout settlement - non-cash release from AOCI	0		0		0		0		(140	)	0		(140	)	0
UK pension buyout settlement - non-cash tax release from AOCI	0		0		0		0		23		0		23		0
Special Charges - non-cash impairment	0		(1	)	(1	)	0		(12	)	0		(13	)	(1	)
Net Income, excluding gain on sale of businesses, non-cash impairment charges and non-cash pension buyout settlement	$81		$89		$113		$111		$141		$114		$335		$314

Operating Cash Flow Conversion	-99	%	-30	%	101	%	205	%	1683	%	98	%	114	%	101	%
Free Cash Flow Conversion	-160	%	-73	%	59	%	172	%	106	%	57	%	26	%	61	%


Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)


2022
	Q1		Q2		Q3		Q4		Total

Net Income	82		112		12				206
Net Income margin	6.4	%	8.2	%	0.9	%			5.1	%
Depreciation	28		28		27				83
Amortization	30		32		31				93
Interest Expense (Income), net	11		10		7				28
Income Tax Expense	16		24		5				45
EBITDA	167		206		82				455
Share-based Compensation	9		9		10				28
Restructuring & Realignment	4		8		6				18
UK Pension Settlement	-		-		140				140
Special Charges	2		3		14				19
Loss/(Gain) from sale of business	(1	)	-		-				(1	)
Adjusted EBITDA	181		226		252				659
Adjusted EBITDA Margin	14.2	%	16.6	%	18.3	%			16.4	%

2021
	Q1		Q2		Q3		Q4		Total

Net Income	87		113		114		113		427
Net Income margin	6.9	%	8.4	%	9.0	%	8.5	%	8.2	%
Depreciation	30		29		31		28		118
Amortization	32		33		31		31		127
Interest Expense (Income), net	19		19		20		11		69
Income Tax Expense	27		25		19		13		84
EBITDA	195		219		215		196		825
Share-based Compensation	9		8		8		8		33
Restructuring & Realignment	8		6		2		6		22
Special Charges	3		3		2		4		12
Loss/(Gain) from sale of business	-		(2	)	-		-		(2	)
Adjusted EBITDA	215		234		227		214		890
Adjusted EBITDA Margin	17.1	%	17.3	%	17.9	%	16.2	%	17.1	%


Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Water Infrastructure

2022
	Q1		Q2		Q3		Q4		Total

Operating Income	74		108		104				286
Depreciation	11		11		11				33
Amortization	2		3		1				6
Other non-operating expense, excluding interest income	(4	)	1		-				(3	)
EBITDA	83		123		116				322
Share-based Compensation	1		-		-				1
Restructuring & Realignment	1		3		3				7
Adjusted EBITDA	85		126		119				330
Adjusted EBITDA Margin	15.9	%	21.4	%	20.7	%			19.5	%

2021
	Q1		Q2		Q3		Q4		Total

Operating Income	71		93		101		122		387
Depreciation	11		11		11		10		43
Amortization	2		2		1		3		8
Other non-operating expense, excluding interest income	(2	)	(2	)	1		(2	)	(5	)
EBITDA	82		104		114		133		433
Share-based Compensation	1		-		1		-		2
Restructuring & Realignment	5		4		1		2		12
Adjusted EBITDA	88		108		116		135		447
Adjusted EBITDA Margin	17.3	%	19.0	%	21.2	%	21.7	%	19.9	%


Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Applied Water

2022
	Q1		Q2		Q3		Q4		Total

Operating Income	59		61		77				197
Depreciation	5		4		4				13
Amortization	-		1		-				1
Other non-operating expense, excluding interest income	(1	)	-		(1	)			(2	)
EBITDA	63		66		80				209
Share-based Compensation	1		1		2				4
Restructuring & Realignment	1		2		1				4
Special Charges	-		-		-				-
Loss/(Gain) from sale of business	-		-		-				-
Adjusted EBITDA	65		69		83				217
Adjusted EBITDA Margin	15.3	%	16.1	%	18.1	%			16.5	%

2021
	Q1		Q2		Q3		Q4		Total

Operating Income	66		64		60		50		240
Depreciation	5		5		5		5		20
Amortization	1		1		-		-		2
Other non-operating expense, excluding interest income	-		(1	)	-		(2	)	(3	)
EBITDA	72		71		65		53		261
Share-based Compensation	1		1		1		1		4
Restructuring & Realignment	1		2		2		2		7
Special Charges	1		-		-		-		1
Loss/(Gain) from sale of business	-		(2	)	-		-		(2	)
Adjusted EBITDA	75		72		68		56		271
Adjusted EBITDA Margin	19.1	%	17.4	%	17.0	%	13.8	%	16.8	%


Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Measurement & Control Solutions

2022
	Q1		Q2		Q3		Q4		Total

Operating Income	(10	)	(5	)	(2	)			(17	)
Depreciation	9		8		8				25
Amortization	25		26		27				78
Other non-operating expense, excluding interest income	-		(1	)	(1	)			(2	)
EBITDA	25		28		32				85
Share-based Compensation	1		2		2				5
Restructuring & Realignment	2		3		2				7
Adjusted EBITDA	27		34		48				109
Adjusted EBITDA Margin	8.6	%	9.8	%	13.8	%			10.8	%

2021
	Q1		Q2		Q3		Q4		Total

Operating Income	9		13		7		(17	)	12
Depreciation	9		10		11		8		38
Amortization	27		27		27		26		107
Other non-operating expense, excluding interest income	(1	)	(1	)	-		-		(2	)
EBITDA	44		49		45		17		155
Share-based Compensation	1		2		1		2		6
Restructuring & Realignment	2		-		(1	)	2		3
Adjusted EBITDA	47		51		45		21		164
Adjusted EBITDA Margin	13.3	%	13.9	%	14.2	%	7.1	%	12.3	%

View source version on businesswire.com: https://www.businesswire.com/news/home/20221031005753/en/

Xylem Reports Third Quarter 2022 Results